Standout Papers

Global burden of NAFLD and NASH: trends... 2004 2026 2011 2018 3.7k
  1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention (2017)
    Zobair M. Younossi, Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
  2. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy (2009)
    Vijayaprakash Suppiah, Max Moldovan et al. Nature Genetics
  3. Beyond insulin resistance in NASH: TNF-α or adiponectin? (2004)
    Jason M. Hui, Alex Hodge et al. Hepatology
  4. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (2018)
    Konstantin Kazankov, Simon Mark Dahl Baunwall et al. Nature Reviews Gastroenterology & Hepatology
  5. Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis (2011)
    Helen M. Parker, Nathan A. Johnson et al. Journal of Hepatology
  6. Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis (2012)
    Shelley E. Keating, Daniel Hackett et al. Journal of Hepatology
  7. Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (2013)
    Paul Angulo, Elisabetta Bugianesi et al. Gastroenterology
  8. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission (2019)
    Shiv Kumar Sarin, Manoj Kumar et al. ˜The œLancet. Gastroenterology & hepatology
  9. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression (2017)
    Reem Waziry, Behzad Hajarizadeh et al. Journal of Hepatology
  10. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review (2016)
    Ryuki Hashida, Takumi Kawaguchi et al. Journal of Hepatology

Immediate Impact

8 by Nobel laureates 6 from Science/Nature 166 standout
Sub-graph 1 of 18

Citing Papers

Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
Acquisition of epithelial plasticity in human chronic liver disease
2024 StandoutNature
43 intermediate papers

Works of Jacob George being referenced

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Animal models of nonalcoholic fatty liver disease
2010
and 21 more

Author Peers

Author Last Decade Papers Cites
Jacob George 16021 8901 4726 5492 589 29.3k
David E. Kleiner 31134 17152 4177 7768 510 49.1k
Kazuaki Chayama 15457 14718 2929 7403 1.4k 44.3k
Frank Tacke 21618 15955 11216 8919 695 43.6k
Christian Trautwein 14942 12695 6767 9567 700 35.2k
Dieter Häussinger 13963 14545 2907 10071 814 39.0k
Roger Williams 15086 14337 4407 14055 817 45.0k
Masao Omata 17387 19210 3699 9861 1.0k 49.9k
Vincent Wai‐Sun Wong 31784 20258 1178 4855 619 42.6k
Atsushi Nakajima 7756 3496 1342 4697 754 19.4k
David Adams 8446 8049 8429 6293 689 33.5k

All Works

Loading papers...

Rankless by CCL
2026